Objective Stem cell treatment is a well-recognized experimental treatment among patients with Parkinson’s disease (PD), for which there are high expectations of a positive impact. Acupuncture with bee venom is one of the most popular complementary and alternative treatments for PD. Patient knowledge and attitudes towards these experimental treatments are unknown. Methods Using a 12-item questionnaire, a nationwide survey was conducted of 963 PD patients and 267 caregivers in 44 Korean Movement Disorders Society member hospitals from April 2013 to June 2013. The survey was performed by trained interviewers using conventional methods. Results Regarding questions on experimental treatments using stem cells or bee venom acupuncture, 5.1–17.7% of PD patients answered questions on safety, efficacy, and evidence-based practice incorrectly; however, more than half responded that they did not know the correct answer. Although safety and efficacy have not been established, 55.5% of PD patients responded that they were willing to receive stem cell treatment. With regard to participating in experimental treatments, there was a strong correlation between stem cell treatment and bee venom acupuncture (p < 0.0001, odds ratio = 5.226, 95% confidence interval 3.919–6.969). Younger age, higher education, and a longer duration of PD were all associated with a correct understanding of experimental treatments. Conclusions Our data suggest that relatively few PD patients correctly understand the safety and efficacy of experimental treatments and that PD patients are greatly interested in new treatments. We hope that our data will be used to educate or to plan educational programs for PD patients and caregivers.
Citations
Citations to this article as recorded by
Knowledge, Attitude, and Practice of Bee Venom Acupuncture Therapy on Rheumatoid Arthritis Among Patients in Saudi Arabia Shahd E Sharaf, Safaa Alsanosi, Abdullah R Alzahrani, Saeed S Al-Ghamdi, Sharaf E Sharaf, Nahla Ayoub International Journal of General Medicine.2022; Volume 15: 1171. CrossRef
Comparison of Patient and Expert Perceptions of the Attainment of Research Milestones in Parkinson's Disease Patrick Bodilly Kane, Daniel M. Benjamin, Roger A. Barker, Anthony E. Lang, Todd Sherer, Jonathan Kimmelman Movement Disorders.2021; 36(1): 171. CrossRef
A Scoping Review of Patient and Public Perspectives on Cell and Gene Therapies Karen Macpherson, Olalekan Lee Aiyegbusi, Lauren Elston, Susan Myles, Jennifer Washington, Nisha Sungum, Mark Briggs, Philip Newsome, Melanie Calvert Regenerative Medicine.2021; 16(11): 1005. CrossRef
Patient and public perspectives on cell and gene therapies: a systematic review Olalekan Lee Aiyegbusi, Karen Macpherson, Lauren Elston, Susan Myles, Jennifer Washington, Nisha Sungum, Mark Briggs, Philip N. Newsome, Melanie J. Calvert Nature Communications.2020;[Epub] CrossRef
Knowledge, attitudes and perceptions of Parkinson's disease: A cross-sectional survey of Asian patients Onanong Jitkritsadakul, Nonglak Boonrod, Roongroj Bhidayasiri Journal of the Neurological Sciences.2017; 374: 69. CrossRef
Attitudes to Stem Cell Therapy Among Ischemic Stroke Survivors in the Lund Stroke Recovery Study Joseph Aked, Hossein Delavaran, Olle Lindvall, Bo Norrving, Zaal Kokaia, Arne Lindgren Stem Cells and Development.2017; 26(8): 566. CrossRef
Professional ethics in complementary and alternative medicines in management of Parkinson’s disease Hee Jin Kim, Beomseok Jeon, Sun Ju Chung Journal of Parkinson's Disease.2016; 6(4): 675. CrossRef